Functional Role of Cell Surface Integrins on Human Trophoblast Cell Migration: Regulation by TGF-beta, IGF-II, and IGFBP-1
Overview
Authors
Affiliations
Trophoblast invasion of the human uterus is stringently controlled by the microenvironment. Invasive extravillous trophoblast cells in situ as well as in culture express a selective repertoire of cell surface integrins. Since migration is a necessary step in the invasion cascade, we tested whether certain integrins or invasion-regulating molecules, i.e., TGF-beta, IGF-II, and IGFBP-1 produced at the fetomaternal interface had a functional role on trophoblast migration. Flow cytometric analysis of integrin expression and the use of an in vitro cell migration assay revealed that exogenous TGF-beta upregulates integrin expression and reduces migratory ability to the invasive trophoblast, whereas IGF-II has no effect on integrin expression but stimulates migration. Trophoblast migration was inhibited in the presence of alpha 5 and beta 1 integrin blocking antibodies, indicating its dependence on the expression of these subunits. Furthermore, IGFBP-1, which contains an RGD sequence recognizing certain integrins, stimulated migration, an effect that was blocked by pretreatment with anti-alpha 5 or -beta 1 blocking Abs. These studies demonstrate that the migration of first trimester invasive trophoblast in vitro (1) requires the expression of alpha 5 and beta 1 integrin subunits, (2) is inhibited by TGF-beta, possibly due to increased cell adhesiveness to the extracellular matrix, (3) is stimulated by IGF-II by an as yet undetermined mechanism, and (4) is stimulated by IGFBP-1, likely by interaction with the RGD binding site of the alpha 5 beta 1 integrin. The invasion-regulating effects of TGF-beta, IGF-II, and IGFBP-1 may thus, at least in part, be due to their migration-regulating effects on the invasive trophoblast.
Horvat Mercnik M, Schliefsteiner C, Sanchez-Duffhues G, Wadsack C Hum Reprod Update. 2024; 30(4):442-471.
PMID: 38519450 PMC: 11215164. DOI: 10.1093/humupd/dmae007.
Modulation of fetoplacental growth, development and reproductive function by endocrine disrupters.
Basak S, Varma S, Duttaroy A Front Endocrinol (Lausanne). 2023; 14:1215353.
PMID: 37854189 PMC: 10579913. DOI: 10.3389/fendo.2023.1215353.
Mechanistic insights into the development of severe fetal growth restriction.
Gumina D, Su E Clin Sci (Lond). 2023; 137(8):679-695.
PMID: 37186255 PMC: 10241202. DOI: 10.1042/CS20220284.
Blake B, Rickard B, Fenton S Front Toxicol. 2022; 4:881347.
PMID: 35548680 PMC: 9081605. DOI: 10.3389/ftox.2022.881347.
Aberdeen G, Babischkin J, Lindner J, Pepe G, Albrecht E Endocrinology. 2022; 163(4).
PMID: 35134145 PMC: 8896163. DOI: 10.1210/endocr/bqac012.